SION - NASDAQ

Sionna Therapeutics, Inc.

SION·NASDAQ

$36.70

-10%

HealthcareBiotechnology

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.66B

EPS-1.8800

P/E Ratio-19.52

Earnings Date08/10/2026

sion

EPS

Last Annual Value

-1.88

3-Year CAGR

-27%

5-Year CAGR

-16%

10-Year CAGR

-8%

Adjust for Inflation

Sionna Therapeutics, Inc. Competitors Analysis of EPS

SION · NASDAQ

Company	EPS	CAGR 3Y	CAGR 5Y	CAGR 10Y
Sionna Therapeutics, Inc. NASDAQ:SION	-1.88	N/A	N/A	N/A
Vera Therapeutics, Inc. NASDAQ:VERA	-4.66	N/A	N/A	N/A
Janux Therapeutics, Inc. NASDAQ:JANX	-1.83	N/A	N/A	N/A
Maze Therapeutics, Inc. NASDAQ:MAZE	-3.05	N/A	N/A	N/A
Ardelyx, Inc. NASDAQ:ARDX	-0.26	N/A	N/A	N/A
Celldex Therapeutics, Inc. NASDAQ:CLDX	-3.90	N/A	N/A	N/A
Immunome, Inc. NASDAQ:IMNM	-2.43	N/A	N/A	N/A
Xeris Biopharma Holdings, Inc. NASDAQ:XERS	0.00	N/A	N/A	N/A
Biohaven Ltd. NYSE:BHVN	-6.86	N/A	N/A	N/A

Sionna Therapeutics, Inc. Fair Value Envelope

SION · NASDAQ

Our analysis suggests that SION has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $36.7, this represents a potential HIDDEN relative to our calculated worth for Sionna Therapeutics, Inc..

HIDDEN

Intrinsic Value

Current Price: $36.7

Related Guides

Blog Categories

Continue your SION research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.